Scotia Capital Inc. Novartis Ag Transaction History

Scotia Capital Inc.

  • $17.8 Billion
  • Q3 2024

A detailed history of Scotia Capital Inc. transactions in Novartis Ag stock. As of the latest transaction made, Scotia Capital Inc. holds 46,529 shares of NVS stock, worth $4.65 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
46,529
Previous 43,207 7.69%
Holding current value
$4.65 Million
Previous $4.6 Million 16.35%
% of portfolio
0.03%
Previous 0.03%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$106.13 - $120.89 $352,563 - $401,596
3,322 Added 7.69%
46,529 $5.35 Million
Q2 2024

Aug 14, 2024
BUY
$92.57 - $107.37 $199,395 - $231,274
2,154 Added 5.25%
43,207 $4.6 Million
Q1 2024

May 14, 2024
SELL
$95.27 - $108.47 $252,084 - $287,011
-2,646 Reduced 6.06%
41,053 $3.97 Million
Q4 2023

Feb 12, 2024
SELL
$92.27 - $101.54 $98,452 - $108,343
-1,067 Reduced 2.38%
43,699 $4.41 Million
Q3 2023

Nov 14, 2023
BUY
$94.73 - $105.13 $371,720 - $412,530
3,924 Added 9.61%
44,766 $4.56 Million
Q2 2023

Aug 03, 2023
SELL
$92.52 - $104.91 $154,600 - $175,304
-1,671 Reduced 3.93%
40,842 $4.12 Million
Q1 2023

May 11, 2023
BUY
$80.03 - $92.81 $21,287 - $24,687
266 Added 0.63%
42,513 $3.91 Million
Q4 2022

Feb 09, 2023
BUY
$75.55 - $92.52 $52,129 - $63,838
690 Added 1.66%
42,247 $3.83 Million
Q3 2022

Nov 10, 2022
SELL
$74.61 - $87.26 $63,120 - $73,821
-846 Reduced 2.0%
41,557 $3.16 Million
Q2 2022

Aug 05, 2022
SELL
$80.52 - $93.75 $1.91 Million - $2.23 Million
-23,762 Reduced 35.91%
42,403 $3.58 Million
Q1 2022

May 09, 2022
SELL
$80.11 - $90.62 $287,675 - $325,416
-3,591 Reduced 5.15%
66,165 $5.81 Million
Q4 2021

Feb 11, 2022
SELL
$79.7 - $88.13 $9.45 Million - $10.4 Million
-118,510 Reduced 62.95%
69,756 $6.1 Million
Q3 2021

Nov 12, 2021
BUY
$81.78 - $95.14 $996,325 - $1.16 Million
12,183 Added 6.92%
188,266 $15.4 Million
Q2 2021

Aug 12, 2021
SELL
$85.24 - $94.15 $3.13 Million - $3.45 Million
-36,691 Reduced 17.24%
176,083 $16.1 Million
Q1 2021

May 06, 2021
BUY
$83.5 - $98.47 $3.1 Million - $3.66 Million
37,141 Added 21.15%
212,774 $18.2 Million
Q4 2020

Feb 11, 2021
BUY
$78.07 - $94.43 $3.38 Million - $4.09 Million
43,285 Added 32.71%
175,633 $16.6 Million
Q3 2020

Nov 12, 2020
BUY
$82.14 - $91.0 $790,843 - $876,148
9,628 Added 7.85%
132,348 $11.5 Million
Q2 2020

Aug 11, 2020
BUY
$80.93 - $91.1 $4.83 Million - $5.44 Million
59,666 Added 94.63%
122,720 $10.7 Million
Q1 2020

May 15, 2020
BUY
$70.67 - $99.01 $476,033 - $666,931
6,736 Added 11.96%
63,054 $5.2 Million
Q4 2019

Feb 13, 2020
BUY
$84.35 - $95.37 $185,148 - $209,337
2,195 Added 4.06%
56,318 $5.33 Million
Q3 2019

Nov 14, 2019
BUY
$85.54 - $94.26 $770,458 - $848,999
9,007 Added 19.96%
54,123 $4.7 Million
Q2 2019

Aug 13, 2019
SELL
$75.4 - $92.8 $525,764 - $647,094
-6,973 Reduced 13.39%
45,116 $4.12 Million
Q1 2019

May 15, 2019
SELL
$75.32 - $86.15 $238,613 - $272,923
-3,168 Reduced 5.73%
52,089 $5.01 Million
Q4 2018

Feb 11, 2019
BUY
$73.66 - $82.02 $217,297 - $241,959
2,950 Added 5.64%
55,257 $4.74 Million
Q3 2018

Nov 14, 2018
SELL
$66.94 - $77.43 $44,582 - $51,568
-666 Reduced 1.26%
52,307 $4.51 Million
Q2 2018

Aug 13, 2018
BUY
$64.91 - $73.36 $35,051 - $39,614
540 Added 1.03%
52,973 $4.26 Million
Q1 2018

May 15, 2018
SELL
$70.39 - $84.15 $64,406 - $76,997
-915 Reduced 1.72%
52,433 $4.24 Million
Q4 2017

Feb 13, 2018
SELL
$72.33 - $77.64 $958,734 - $1.03 Million
-13,255 Reduced 19.9%
53,348 $4.48 Million
Q3 2017

Nov 14, 2017
SELL
$74.14 - $77.27 $6,746 - $7,031
-91 Reduced 0.14%
66,603 $5.72 Million
Q2 2017

Aug 15, 2017
BUY
N/A
66,694
66,694 $5.57 Million

Others Institutions Holding NVS

# of Institutions
1,427
Shares Held
130M
Call Options Held
1.12M
Put Options Held
1.83M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $215B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Scotia Capital Inc. Portfolio

Follow Scotia Capital Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Scotia Capital Inc., based on Form 13F filings with the SEC.

News

Stay updated on Scotia Capital Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email